Why the study?
Does long-term oral amiodarone therapy result in predictable cardiac concentrations based on plasma levels?
Does long-term oral amiodarone therapy result in predictable cardiac concentrations based on plasma levels?
There is a linear relationship between plasma and cardiac concentrations of amiodarone during long-term therapy, allowing prediction of cardiac levels from routine blood analysis.
Answers are grounded in this paper and cite their sources.
Plasma monitoring may aid amiodarone dosing; hypothesis-generating and requires prospective validation before practice change.
A study of plasma and cardiac concentrations of amiodarone during the course of long-term oral therapy was made possible by the improvement of analytical high performance liquid chromatography of plasma and tissue extracts. The plasma level was found to increase linearly with the daily dose of the drug, above a threshold value of c. 1 . 9 mg kg-1 day-1. Similarly, the cardiac content increased linearly with the daily dose, with no threshold, showing that the drug is taken up and accumulated in the cardiac tissue, with no obvious difference between atrial and ventricular samples (P greater than 0 . 05). Both plasma and heart showed no saturation at high drug intake, a justification for increasing the oral intake in severe cases. The linear relationship between tissue and blood concentrations allows a prediction of the cardiac level from a simple and routine blood analysis.
No takes yet. Share an insight, caveat, or question.
Debbas et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: